Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Analyst Downgrade Weighs on Wolfspeed’s Stock Outlook

Robert Sasse by Robert Sasse
January 22, 2026
in Analysis, Semiconductors, Tech & Software
0
Wolfspeed Stock
0
SHARES
17
VIEWS
Share on FacebookShare on Twitter

Market sentiment toward Wolfspeed, a key player in silicon carbide and gallium nitride materials, has grown more cautious following a significant price target cut from Susquehanna. The financial firm slashed its target for the semiconductor company’s shares from $30 to $20, though it maintained a “Neutral” rating on the stock. The immediate market reaction to this adjustment has been muted.

Divergent Views on Future Performance

While Susquehanna’s revised target represents a 33.3% reduction, the broader analyst community paints an even more restrained picture. The consensus average price target for Wolfspeed stands at just $8.83. Current recommendations are split, highlighting a lack of uniform conviction: three analysts advocate a “Buy,” one suggests “Hold,” and four advise “Sell.” This divergence underscores the uncertain path ahead for the company.

Financial Metrics and Trading Activity

The stock closed yesterday’s session with a loss of approximately 5.4%, trading within a range of $19.4 to $19.7. It opened today at $20.19 and is hovering near the $20 level. Notably, trading volume has contracted sharply, with the slowest session seeing only 558,436 shares change hands—a figure roughly 52% below the average daily volume.

Should investors sell immediately? Or is it worth buying Wolfspeed?

Key Financial Data:
* Market Capitalization: Approximately $523 million
* Trailing P/E (EPS): -31.04 (indicating losses)
* 50-Day Moving Average: $19.20
* 200-Day Moving Average: $13.60
* 52-Week Range: $8.05 – $36.60

In its most recent quarterly report, Wolfspeed delivered results that slightly exceeded expectations. The company reported a loss per share of -$0.63, better than the estimated -$0.68, while revenue reached $196.8 million against a forecast of $195.37 million. Despite this outperformance, the firm remains unprofitable, a status clearly reflected in its negative earnings multiple.

The near-term outlook for the equity is likely constrained by the dual pressures of reduced analyst targets and ongoing financial losses. A meaningful turnaround in margins or bottom-line results would be necessary to prompt a positive reassessment of ratings and targets. Until such progress is demonstrated, the stock is expected to remain under pressure from the current analyst stance and its fundamental performance profile.

Ad

Wolfspeed Stock: Buy or Sell?! New Wolfspeed Analysis from February 7 delivers the answer:

The latest Wolfspeed figures speak for themselves: Urgent action needed for Wolfspeed investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Wolfspeed: Buy or sell? Read more here...

Tags: Wolfspeed
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Potbelly Stock
Analysis

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026
Next Post
Strategy Stock

Strategy's Financial Milestone: A Shift in Capital Structure and Bitcoin Strategy

Coeur Mining Stock

Coeur Mining's Strategic Acquisition Gains Momentum Amid Strong Operational Performance

Nvidia Stock

Nvidia's Vision: A Trillion-Dollar Infrastructure Era Dawns

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com